Compare Medpace Holdings Inc (MEDP) vs ArcelorMittal SA (MT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs ArcelorMittal SA — how do they compare? Medpace Holdings Inc trades at $607 (market cap $16.90B), while ArcelorMittal SA trades at $74.2 (market cap $55.88B). The key difference: ArcelorMittal SA is far larger — about 3.3× Medpace Holdings Inc's market cap, and ArcelorMittal SA pays a 0.81% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | MT | |
|---|---|---|
Market Cap | $16.90B | $55.88B |
Sector | Technology | Basic Materials |
52-Week High | $620.59 | $75.35 |
52-Week Low | $393.42 | $32.44 |
Enterprise Value | $16.52B | $65.45B |
Dividend Yield | — | 0.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About ArcelorMittal SA
ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →
